DECEMBER, 2014 Gene-Related Patent Applications Posted - Full application: http://appft1.uspto.gov/netahtml/PTO/srchnum.html
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY
Appl Number Title Assignee Date Issued Country
20140377802 Novel P. Pastoris Pastoris Promoters, and the Use Thereof to Direct Expression of Proteins in Yeast, Preferably Using a Haploid Mating Strategy ALDERBIO HOLDINGS LLC 25-Dec-14 United States
20140370575 GENETICALLY ENHANCED CYANOBACTERIA FOR THE PRODUCTION OF A FIRST CHEMICAL COMPOUND HARBOURING ZN2+, CO2+ OR NI2+ -INDUCIBLE PROMOTERS ALGENOL BIOFUELS INC. 18-Dec-14 United States
20140370574 Metabolically Enhanced Cyanobacterial Cell for the Production of Ethanol Algenol Biofuels Inc. 18-Dec-14 United States
20140356879 GENES CONFERRING TOLERANCE TO ETHANOL AND HIGH TEMPERATURE FOR YEASTS ARCHER DANIELS MIDLAND COMPANY 4-Dec-14 United States
20140370582 SYSTEM AND METHOD FOR DETERMINING INDIVIDUALIZED MEDICAL INTERVENTION FOR A DISEASE STATE Caris MPI, Inc. 18-Dec-14 United States
20140363813 Sperm-Specific Cation Channel, Catsper2, and Uses Therefor CHILDREN'S MEDICAL CENTER CORPORATION 11-Dec-14 United States
20140377804 Filamentous Fungi Having Reduced UDP-Galactofuranose Content DANISCO US INC. 25-Dec-14 United States
20140356908 BINDING MOLECULES ERASMUS UNIVERSITY MEDICAL CENTER 4-Dec-14 Netherlands
20140356907 ANTIBODY PRODUCTION ERASMUS UNIVERSITY MEDICAL CENTER 4-Dec-14 Netherlands
20140356906 METHODS AND PRODUCTS FOR TRANSFECTING CELLS FACTOR BIOSCIENCE INC. 4-Dec-14 United States
20140363878 RECOMBINANT NEGATIVE STRAND VIRUS RNA EXPRESSION SYSTEMS AND VACCINES Garcia-Sastre; Adolfo 11-Dec-14 United States
20140356904 BACULOVIRUS EXPRESSION SYSTEMS Genethon 4-Dec-14 France
20140370506 ASYMMETRIC HAIRPIN TARGET CAPTURE OLIGOMERS GEN-PROBE INCORPORATED 18-Dec-14 United States
20140370500 NONVIRAL TARGETED NANOPARTICLE SYSTEM FOR GENE TRANSFER AND DRUG DELIVERY Ghanavi; Jalaledin 18-Dec-14 Ireland
20140377752 NOVEL SYNTHESIS-REGULATING SRNA AND METHOD FOR PREPARING SAME Korea Advanced Institute of Science and Technology 25-Dec-14 Korea
20140377825 PROCESS FOR THE BIOLOGICAL PRODUCTION OF n-BUTANOL WITH HIGH YIELD METABOLIC EXPLORER 25-Dec-14 France
20140363844 Cyclic Peptide Production National Research Council of Canada 11-Dec-14 United States
20140377768 Novel Antitumor Agent and Method For Screening Same Osaka University 25-Dec-14 Japan
20140377799 METHOD FOR SECRETORY PRODUCTION OF GLYCOPROTEIN HAVING HUMAN-TYPE SUGAR CHAIN USING PLANT CELL Phyton Holdings, LLC 25-Dec-14 United States
20140363810 METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY SEKISUI MEDICAL CO., LTD. 11-Dec-14 Japan
20140377754 Genomic Landscapes of Human Breast and Colorectal Cancers The Johns Hopkins University 25-Dec-14 United States
20140363816 METHODS FOR PREDICTION OF CLINICAL RESPONSE TO RADIATION THERAPY IN CANCER PATIENTS THE REGENTS OF THE UNIVERSITY OF COLORADO 11-Dec-14 United States
20140377769 LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY 25-Dec-14 Canada
20140356866 COMPUTER READABLE MEDIUM FOR ENABLING A COMPUTER TO CARRY OUT PROVISION OF INFORMATION ON COLON CANCER AND MARKER AND KIT FOR OBTAINING INFORMATION ON COLON CANCER THE UNIVERSITY OF TOKYO 4-Dec-14 Japan
20140370573 METHOD FOR PRODUCING ISOPROPANOL AND RECOMBINANT YEAST CAPABLE OF PRODUCING ISOPROPANOL TOYOTA JIDOSHA KABUSHIKI KAISHA 18-Dec-14 Japan
20140363807 Genetic Marker for Detection of Human Papillomavirus TROVAGENE, INC. 11-Dec-14 United States
20140377757 COMPOSITIONS AND METHODS FOR SCREENING FOR CREATINE TRANSPORTER DEFICIENCY UNIVERSITY OF CINCINNATI 25-Dec-14 United States
20140356961 USE OF PHASED SMALL RNAS FOR SUPPRESSION OF PLANT DEFENSE AND OTHER PLANT GENES University of Delaware Technology Park 4-Dec-14 United States
20140356878 Primers and Methods for Determining RhD Zygosity Wake Forest Institute of Regenerative Medicine 4-Dec-14 United States
COMBINATORIAL CHEMISTRY TECHNOLOGY
Appl Number Title Assignee Date Issued Country
20140371111 SYSTEM AND METHOD FOR DETERMINING INDIVIDUALIZED MEDICAL INTERVENTION FOR A DISEASE STATE Caris MPI, Inc. 18-Dec-14 United States
20140357510 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt Deutsches Krebsforschungszentrum 4-Dec-14 Germany
20140371100 METHOD OF NUCLEIC ACID AMPLIFICATION ILLUMINA, INC. 18-Dec-14 United States
20140371092 METHODS FOR ASSESSING ENDOMETRIAL RECEPTIVITY OF A PATIENT AFTER CONTROLLED OVARIAN HYPERSTIMULATION INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 18-Dec-14 France
20140357517 RADIATION EXPOSURE DIAGNOSTIC MARKER IGFBP-5, COMPOSITION FOR RADIATION EXPOSURE DIAGNOSIS BY MEASURING THE EXPRESSION LEVEL OF THE MARKER, RADIATION EXPOSURE DIAGNOSTIC KIT COMPRISING THE COMPOSITION, AND METHOD FOR DIAGNOSING RADIATION EXPOSURE USING THE MARKER Korea Institute of Radiological & Medical Science 4-Dec-14 Korea
20140364334 CONGESTIVE HEART FAILURE BIOMARKERS Nuclea Biotechnologies, Inc. 11-Dec-14 United States
20140357530 FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS, COMPOSITIONS, METHODS, KNOCK OUT LIBRARIES AND APPLICATIONS THEREOF THE BROAD INSTITUTE INC. 4-Dec-14 United States
20140364338 Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof The Regents of the University of California 11-Dec-14 United States
20140364331 RECURRENT GENE FUSIONS IN PROSTATE CANCER THE REGENTS OF THE UNIVERSITY OF MICHIGAN 11-Dec-14 United States
20140378316 METHOD OF PURIFYING RNA BINDING PROTEIN-RNA COMPLEXES The Rockefeller University 25-Dec-14 United States
20140371099 BIOMARKER FOR CHRONIC INFLAMMATORY LUNG DISEASES UNIVERSITE DE STRASBORG 18-Dec-14 France
DATA PROCESSING
Appl Number Title Assignee Date Issued Country
20140379379 SYSTEM AND METHOD FOR REAL TIME CLINICAL QUESTIONS PRESENTATION AND MANAGEMENT KONINKLIJKE PHILIPS N.V. 25-Dec-14 Netherlands
20140358448 COMPUTER READABLE MEDIUM FOR ENABLING A COMPUTER TO CARRY OUT PROVISION OF INFORMATION ON HEPATOCELLULAR CARCINOMA AND MARKER AND KIT FOR OBTAINING INFORMATION ON HEPATOCELLULAR CARCINOMA THE UNIVERSITY OF TOKYO 4-Dec-14 Japan
DRUG
Appl Number Title Assignee Date Issued Country
20140357698 MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE Academisch Ziekenhuis Leiden 4-Dec-14 Netherlands
20140378527 MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE Academisch Ziekenhuis Leiden 25-Dec-14 Netherlands
20140370007 METHOD OF DIRECTED DIFFERENTIATION PRODUCING CORNEAL ENDOTHELIAL CELLS, COMPOSITIONS THEREOF, AND USES THEREOF Advanced Cell Technology, Inc. 18-Dec-14 United States
20140356450 AGENT FOR ACTIVATING SIRTUIN GENE CONTAINING EGG SHELL MEMBRANE INGREDIENT AND COMPOSITION USING THE SAME ALMADO Inc. 4-Dec-14 Japan
20140363465 MYCOBACTERIAL VACCINE VECTORS AND METHODS OF USING THE SAME Beth Israel Deaconess Medical Center, Inc. 11-Dec-14 United States
20140356387 METHOD FOR INDUCING IMMUNE TOLERANCE THROUGH TARGETTED GENE EXPRESSION BLOODCENTER RESEARCH FOUNDATION 4-Dec-14 United States
20140357702 MicroRNA Expression Profile Associated With Pancreatic Cancer Board of Regents of the University of Oklahoma 4-Dec-14 United States
20140378435 Inhibition of Filovirus Entry Into Cells and Uses Thereof Board of Regents, University of Texas System 25-Dec-14 United States
20140370051 CHIMERIC NON-INTEGRATING LENTIVIRAL GENOMES AS VACCINES AGAINST HIV-1 BOE TECHNOLOGY GROUP CO., LTD 18-Dec-14 China P Rep
20140377252 METHOD FOR PREDICTING THE RESPONSE TO TREATMENT WITH AN HER2-BLOCKING AGENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 25-Dec-14 France
20140357700 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA CITY OF HOPE 4-Dec-14 United States
20140356346 MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE CSL Behring GmbH 4-Dec-14 Germany
20140378529 COLLATERAL GENE INACTIVATION BIOMARKERS AND TARGETS FOR CANCER THERAPY DANA-FARBER CANCER INSTITUTE, INC. 25-Dec-14 United States
20140377214 MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES Indiana University Research and Technology Corp. 25-Dec-14 United States
20140363406 ESTROGEN METABOLITE LEVELS AND CYP1B1 POLYMORPHISMS IN LUNG CANCER DIAGNOSIS, PROGNOSIS, AND RISK ASSESSMENT Institute for Cancer Research d/b/a 11-Dec-14 United States
20140371300 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 18-Dec-14 Korea
20140364488 RPGRIP1 GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS Massachusetts Eye and Ear Infirmary 11-Dec-14 United States
20140364489 Pharmaceutical Composition Producing antioxidant, antimicrobal, antitoxic protein - human lactoferrin, production process and therapeutic method. Obschestvo s ogranichennoi otvetstvennostyu "NTpharma" 11-Dec-14 Russia
20140357550 Pharmaceutical Composition for Treatment of Acute Toxic Conditions OOO "NTpharma" 4-Dec-14 Russia
20140369979 VECTOR SIMULTANEOUSLY EXPRESSING DODECAMERIC TRAIL AND HSV-TK SUICIDE GENES, AND ANTICANCER STEM CELL THERAPEUTIC AGENT USING SAME POSTECH ACADEMY-INDUSTRY FOUNDATION 18-Dec-14 Korea
20140356370 METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS REGENERON PHARMACEUTICALS, INC. 4-Dec-14 United States
20140363502 Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration Resveratrol Partners, LLC 11-Dec-14 United States
20140364482 REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS RXi Pharmaceuticals Corporation 11-Dec-14 United States
20140356455 PLURIPOTENT CELL LINES AND METHODS OF USE THEREOF The Board of Trustees of the Leland Stanford Junior University 4-Dec-14 United States
20140371142 MYONECTIN (CTRP15), COMPOSITIONS COMPRISING SAME, AND METHODS OF USE THE JOHNS HOPKINS UNIVERSITY 18-Dec-14 United States
20140364434 Biomarkers for Prediction of Response to PARP Inhibition in Breast Cancer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 11-Dec-14 United States
20140364460 USE OF FATOSTATIN FOR TREATING CANCER HAVING A p53 MUTATION THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 11-Dec-14 United States
20140356328 SUBFAMILY E SIMIAN ADENOVIRUSES A1321, A1325, A1295, A1309, A1316 AND A1322 AND USES THEREOF The Trustees of the University of Pennsylvania 4-Dec-14 United States
20140377224 Method of Treating or Retarding the Development of Blindness THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 25-Dec-14 United States
20140363436 DIAGNOSING AND TREATING IGA NEPHROPATHY THE UAB RESEARCH FOUNDATION 11-Dec-14 United States
20140357660 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY The United State of America, as represented by the Secretary, Dept. of Health and Human Services 4-Dec-14 United States
20140371325 NITISINONE FOR TREATMENT OF OCULOCUTANEOUS/OCULAR ALBINISM AND FOR INCREASING PIGMENTATION The United States of America, as represented by the Secretary, Department of Health and Human Serv 18-Dec-14 United States
20140377179 COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES The United States of America,as represented by the Secretary, Department of Health & Human Services 25-Dec-14 United States
20140363519 ACTIVATOR OF GENE EXPRESSION OF MOLECULAR CHAPERONE GENE COMPRISING EGGSHELL MEMBRANE COMPONENT AND COMPOSITION THEREOF The University of Tokyo 11-Dec-14 United States
20140377235 METHODS FOR USING SYNTHETIC TRITERPENOIDS IN THE TREATMENT OF BONE OR CARTILAGE DISEASES OR CONDITIONS Trustees of Dartmouth College 25-Dec-14 United States
20140378536 TRANSCRIPTIONAL REPRESSION LEADING TO PARKINSON'S DISEASE VALTED, LLC 25-Dec-14 United States
20140357693 METABOLIC GENE MESENCHYMAL SIGNATURES AND USES THEREOF Whitehead Institute for Biomedical Research 4-Dec-14 United States
FOOD OR EDIBLE MATERIAL
Appl Number Title Assignee Date Issued Country
20140356518 MICROORGANISM FOR SIMULTANEOUSLY PRODUCING L-AMINO ACID AND RIBOFLAVIN, AND METHOD FOR PRODUCING L-AMINO ACID AND RIBOFLAVIN USING SAME CJ CHEILJEDANG CORPORATION 4-Dec-14 Korea
20140377407 ALPHA-AMYLASE DSM IP ASSETS B.V. 25-Dec-14 Israel
20140377408 YEAST HAVING RESISTANCE TO FREEZING STRESS NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY 25-Dec-14 Japan
INFORMATION SECURITY
Appl Number Title Assignee Date Issued Country
20140366136 BEHAVIORAL-BASED HOST INTRUSION PREVENTION SYSTEM Sophos Limited 11-Dec-14 United Kingdom
MULTICELLULAR LIVING ORGANISMS
Appl Number Title Assignee Date Issued Country
20140359901 SEED-SPECIFIC PROMOTER IN COTTON Bayer CropScience NV 4-Dec-14 Belgium
20140380528 SIMULTANEOUS GENE SILENCING AND SUPPRESSING GENE SILENCING IN THE SAME CELL Commonwealth Scientific and Industrial Research Organisation 25-Dec-14 Australia
20140366224 PROCESS FOR MODIFYING THE ARCHITECTURE AND IMPROVING THE YIELD OF CROP PLANTS Consejo Superior De Investigaciones Cientificas 11-Dec-14 Spain
20140366218 SOYBEAN BB13 PROMOTER AND ITS USE IN EMBRYO-SPECIFIC EXPRESSION OF TRANSGENIC GENES IN PLANTS E I DU PONT DE NEMOURS AND COMPANY 11-Dec-14 United States
20140366217 MUTANTS OF ALPHA-AMYLASE INHIBITORS ISOLATED FROM PHASEOLUS VULGARIS CAPABLE OF CONTROLLING INSECT PESTS, COMPOSITIONS CONTAINING THESE MUTANTS AND METHOD OF USING THE SAME EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA - EMBRAPA 11-Dec-14 Brazil
20140373194 METHOD AND CONSTRUCTS FOR DELIVERING DOUBLE STRANDED RNA tO PEST ORGANISMS EVGEN N.V. 18-Dec-14 Belgium
20140373193 Use of OsPP18 Gene in Controlling Rice Drought Resistance HUAZHONG AGRICULTURAL UNIVERSITY 18-Dec-14 China P Rep
20140373192 HIGH EFFICIENCY PLANT EXPRESSION PROMOTOR FROM CAPCICUM ANNUUM SERINE HYDROXYMETHYL TRANSFERASE GENE AND USES THEREOF INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY 18-Dec-14 Korea
20140359796 GENETICALLY STERILE ANIMALS Recombinetics, Inc. 4-Dec-14 United States
20140380526 Disruption of CKX3 and at least one other CKX gene in a plant or plant cell leads to improved traits SCHMULLING; Thomas 25-Dec-14 Germany
20140366223 METHODS FOR GENERATING TRANSGENIC PLANTS Syngenta Participations AG 11-Dec-14 Switzerland
20140359898 TRANSGENIC CEREAL PLANTS WITH INCREASED RESISTANCE TO RUST DISEASES THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY 4-Dec-14 United States
20140366219 Increasing Soybean Defense Against Pests University of Tennessee Research Foundation 11-Dec-14 United States
NATURAL RESINS OR DERIVATIVES
Appl Number Title Assignee Date Issued Country
20140364589 BRTCP24 GENE USEFUL FOR CONTROLLING GROWTH OF CABBAGE AND APPLICATION THEREOF VEGETABLE RESEARCH INSTITUTE OF SHANDONG, ACADEMY OF AGRICULTURAL SCIENCES 11-Dec-14 China P Rep
ORGANIC COMPOUNDS
Appl Number Title Assignee Date Issued Country
20140357855 MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE Academisch Ziekenhuis Leiden 4-Dec-14 Netherlands
20140371440 SINGLE-STRANDED ANTIMICROBIAL OLIGONUCLEOTIDES AND USES THEREOF Star Biologics, Inc. 18-Dec-14 United States
PLANTS
Appl Number Title Assignee Date Issued Country
20140366233 Dwarf grapevine 'VDG003' Vineland Research and Innovations Centre Inc. 11-Dec-14 United States
20140366232 Dwarf Grapevine VDG004 Vineland Research and Innovations Centre Inc. 11-Dec-14 United States
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Miracle Ear
What will your miracle sound like?
Miracle Ear Hearing Aids
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact [email protected]
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.